When Major Bleeding Extends Beyond Hospitalization – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Nicholas S. Roetker et al. published in RTPH:
“Major bleeding is not just more common in dialysis; it is more costly after it happens.
In a new Medicare-based study published in RPTH Journal, patients with dialysis-dependent ESKD had longer and more expensive hospitalizations for major bleeding than patients without ESKD.
One year later, the burden remained high: bleeding-related hospitalizations were more frequent, costs were substantially higher, and readmissions were a major driver.
A sharp reminder that bleeding prevention in dialysis is not only a clinical priority, it is also a major health-system priority.”
Title: Health care resource utilization and costs of major bleeding in patients with and without dialysis-dependent end-stage kidney disease: a retrospective study
Authors: Nicholas S. Roetker, Alejandro Victores, Chuanyu Kou, Lori D. Bash, Dena Rosen Ramey, Xuehua Ke, Marc P. Bonaca, James B. Wetmore

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments